GONELLA JACQUES 4
4 · ANTARES PHARMA, INC. · Filed Jun 7, 2018
Insider Transaction Report
Form 4
GONELLA JACQUES
Director10% Owner
Transactions
- Sale
Common Stock
2018-06-05$2.70/sh−23,129$62,448→ 10,506,672 total - Sale
Common Stock
2018-06-06$2.70/sh−20,259$54,699→ 10,486,413 total
Footnotes (1)
- [F1]The sale of common stock reported in this Form 4 was made for estate planning purposes.